Watch BGMSP. Know when insiders buy.
One email the day a filing lands. Free.
BGMSP
Bio Green Med Solution, Inc.
2.81
+0.00 +0.00%
USD · close Sep 7
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $18.6MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$2.2MNET CASH —52W 0.30 – 7.21SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $357K | — | — | −$418K | −$405K | — | — | −$352K | $0 | −$352K | Aug 14 |
| Q1 2026 · Mar 31 | $743K | — | — | −$246K | −$197K | — | — | −$278K | $1K | −$279K | Aug 14 |
| Q4 2025 · Dec 31derived | — | — | — | −$1.1M | −$611K | — | -3.59 | −$33K | — | — | Mar 30 |
| Q3 2025 · Sep 30 | — | — | — | −$992K | −$988K | — | -1.31 | −$434K | — | — | Nov 13 |
| Q2 2025 · Jun 30 | — | — | — | −$1.2M | −$1.3M | — | -0.98 | −$1.1M | — | — | Aug 14 |
| Q1 2025 · Mar 31 | — | — | — | −$4.2M | −$81K | — | 0.00 | −$3.2M | — | — | Aug 14 |
| Q4 2024 · Dec 31derived | — | — | — | −$1.8M | −$3.1M | — | -12.45 | −$1.4M | — | — | Mar 30 |
| Q3 2024 · Sep 30 | — | — | — | −$2.2M | −$2M | — | -43.80 | −$3.1M | $0 | −$3.1M | Nov 13 |
| Q2 2024 · Jun 30 | — | — | — | −$3.6M | −$3.3M | — | -172.18 | −$3.1M | — | — | Nov 13 |
| Q1 2024 · Mar 31 | — | — | — | −$4.4M | −$2.9M | — | -2.27 | −$483K | — | — | Nov 13 |
| Q4 2023 · Dec 31derived | — | — | — | −$5.4M | −$5.3M | — | — | −$3.9M | $0 | −$3.9M | Nov 26 |
| Q3 2023 · Sep 30 | — | — | — | −$6.8M | −$6M | — | — | −$4M | $0 | −$4M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $0 | — | −$8.4M | −$3M | — | -6.45 | −$4.8M | — | — | — | — |
| FY2024 · to Dec 31 | $43K | — | −$12M | −$11.2M | -26074.4% | -502.46 | −$8M | — | — | — | — |
| FY2023 · to Dec 31 | — | — | −$25.5M | −$22.6M | — | -6419.18 | −$16.1M | $6K | −$16.1M | — | — |
| FY2022 · to Dec 31 | — | — | −$27.7M | −$21.2M | — | -27.24 | −$20.8M | $7K | −$20.8M | — | — |
| FY2021 · to Dec 31 | — | — | −$22.4M | −$18.5M | — | -2.09 | −$18.5M | $27K | −$18.6M | — | — |
| FY2020 · to Dec 31 | — | — | −$10.6M | −$8.4M | — | -3.42 | −$7.9M | $96K | −$8M | — | — |
Every number comes from Bio Green Med Solution, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.